Endava plc
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- John Edward Cotterell
- Full Time Employees
- 11,225
- Sector
- Technology
- Industry
- Information Technology Services
- Address
- 125 Old Broad Street London GL United Kingdom EC2N 1AR
- IPO Date
- Jul 27, 2018
- CIK
- 0001656081
- Website
- endava.com
- Similar Companies
- Business
- Endava plc Endava plc (NYSE: DAVA) provides technology-driven business transformation services, specializing in digital product acceleration, advisory and digital strategy, digital engineering, data and artificial intelligence, and operations optimization. The company offers strategy consulting, creative and user interface design, data insights, mobile and Internet of Things solutions, systems architecture, automation, software engineering, test automation, DevOps, cloud computing, and advanced application management; it serves industries including finance and banking, healthcare, telecommunications, retail, payments, gaming, automotive, energy, and private equity. Endava plc operates close-to-client offices across North America and Western Europe, with nearshore delivery centers in Eastern Europe (Romania, Moldova, Bulgaria, Serbia, Slovenia, North Macedonia, Croatia, Bosnia and Herzegovina, Poland), Asia Pacific (Malaysia, Singapore, Australia, Vietnam), and Latin America (Argentina, Uruguay, Mexico, Colombia). Founded in 2000 and headquartered in London, United Kingdom, the company recently announced a strategic partnership with AlixPartners in May 2025 to deliver end-to-end technology solutions across financial services, retail, automotive, energy, telecommunications, and private equity; entered a partnership with OpenAI supporting client acquisitions in 2025; launched Dava.Rise to accelerate enterprise innovation and Dava.X for AI, core modernization, and cloud expertise; strengthened its executive team; and formed a global advisory board amid AI-driven transformation.
Company News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endava plc - DAVA
Endava plc ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses
Securities Fraud Investigation Into Endava plc (DAVA) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Securities Fraud Investigation Into Endava plc (DAVA) Continues -- Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Endava plc (NYSE: DAVA) Scrutinized Amid Board Placing CFO On Leave, 25% Stock Drop -- HBSS
Securities Fraud Investigation Into Endava plc (DAVA) Continues -- Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Securities Fraud Investigation Into Endava plc (DAVA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Endava plc (DAVA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Securities Fraud Investigation Into Endava plc (DAVA) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Securities Fraud Investigation Into Endava plc (DAVA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
This Marathon Petroleum Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday
DAVA ALERT: Endava Investigated for Securities Fraud by Block & Leviton; Investors Should Contact the Firm
Securities Fraud Investigation Into Endava plc (DAVA) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Endava Appoints Conor McShane as Interim Chief Financial Officer
LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology's 4th Summit on Breast Cancer
Endava Partners with Wiz to Deliver Integrated Cloud Security for Enterprise AI Adoption
New Strong Sell Stocks for June 12th
Endava: Execution Needs To Improve Before This Is A Buy (Rating Downgrade)
Endava Analysts Slash Their Forecasts Following Downbeat Q3 Results
Endava plc Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses